The VM Study

The VM & EFA formulas complement each other and are tailored for individuals who are diabetics, pre-diabetics and those at risk. In a double-blind, placebo controlled with crossover at 6 months study performed by Dr. Habib back in 1999-2000, involving 15 patients, 11 of them completed the study for 1 year, Dr. Habib showed without any question, that 55% of the patients with type I diabetes receiving the VM formula had an average decrease of their hemoglobin A1c by 1% after a 6 month period. When switched to the placebo, 90% of the patients had an average increase of their hemoglobin A1c by 1.3% 6 months later. No EFA were used with the original 1999-2000 study. The addition of the EFA formula, along with the Q-10 will add more beneficial effects to the VM formula and therefore Dr. Habib recommends taking the two formulas together.

The system could also be beneficial to individuals with obesity, cardiovascular disease, dyslipidemia and related complications as well as individuals who have sedentary lifestyles.